Pharmaceutical Packaging Moves Up the Value Chain
29 April 2026.Pharmaceutical packaging is becoming strategic, smarter, sustainable and growth-critical
Pharmaceutical packaging is becoming strategic, smarter, sustainable and growth-critical
The global Pharmaceutical Contract Manufacturing market is projected to grow at a CAGR of 7.9% by 2036
The global Pharmaceutical Packaging market is projected to grow at a CAGR of 8.8% by 2036
The global mRNA Cancer Vaccine market is projected to grow at a CAGR of 27.1% by 2036
The global cell & gene therapy market is projected to grow at a CAGR of 17.3% by 2036
Alzheimer’s shifts to early intervention, with innovation reshaping competitive dynamics.
Decentralised trials shift from adoption to execution as complexity rises
The global decentralised clinical trials market is projected to grow at a CAGR of 11.5% by 2036
RA market shifting beyond biologics, driven by access, innovation, and pricing
GLP-1 therapies are transforming obesity treatment and reshaping the global pharmaceutical market
Antibody drug conjugates are reshaping oncology through precision targeting, expanding pipelines and industry partnerships
Ophthalmology shifts to durable growth through biologics, delivery innovation and consolidation.
Ophthalmics offers durable growth amid broader pharma market volatility
Fill-finish capacity now defines biologics launches, valuation strength, and competitive leverage
The global Longevity market is projected to grow at a CAGR of 8.6% by 2036
The global Alzheimer’s Therapeutics market is projected to grow at a CAGR of 18.2% by 2036
Drug discovery outsourcing reshapes pipeline speed, capital efficiency, and competitive advantage
Pharma distribution is becoming a strategic lever shaping access, affordability, scale.
The global Anti-obesity Drugs market 2026-2036 is projected to grow at a CAGR of 24.2% by 2036
Clinical trial supply chains have become strategic engines of feasibility, resilience, and value.